HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Fulgent Genetics (FLGT) Investors with ...
Hagens Berman urges Fulgent Genetics, Inc. (NASDAQ: FLGT) investors who suffered significant losses to submit your losses now. A securities fraud class action has been filed after Fulgent disclosed the DOJ and SEC are conducting investigations
By Hagens Berman Sobol Shapiro LLP
Published - Nov 14, 2022, 12:11 PM ET
Last Updated - Jul 30, 2024, 12:27 AM EDT
SAN FRANCISCO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Fulgent Genetics, Inc. (NASDAQ: FLGT) investors who suffered significant losses to submit your losses now. A securities fraud class action has been filed after Fulgent disclosed the DOJ and SEC are conducting investigations.
Class Period: Mar. 22, 2019 – Aug. 4, 2022
Lead Plaintiff Deadline: Nov. 21, 2022
Visit: www.hbsslaw.com/investor-fraud/FLGT
Contact An Attorney Now: FLGT@hbsslaw.com
844-916-0895
Fulgent Genetics, Inc. (NASDAQ: FLGT) Securities Fraud Class Action:
The litigation focuses on Fulgent’s previously claimed “very strong” and “truly outstanding” financial results.
